Imaging infection/inflammation in the new millennium

Citation
Hjjm. Rennen et al., Imaging infection/inflammation in the new millennium, EUR J NUCL, 28(2), 2001, pp. 241-252
Citations number
98
Categorie Soggetti
Radiology ,Nuclear Medicine & Imaging","Medical Research Diagnosis & Treatment
Journal title
EUROPEAN JOURNAL OF NUCLEAR MEDICINE
ISSN journal
03406997 → ACNP
Volume
28
Issue
2
Year of publication
2001
Pages
241 - 252
Database
ISI
SICI code
0340-6997(200102)28:2<241:IIITNM>2.0.ZU;2-G
Abstract
In the closing half of the past century a wide variety of approaches were d eveloped to visualise infection and inflammation by gamma scintigraphy. Use of autologous leucocytes, labelled with indium-111 or technetium-99m, is s till considered the "gold standard" nuclear medicine technique for the imag ing of infection and inflammation. However, the range of radiopharmaceutica ls used to investigate infectious and non-microbial inflammatory disorders is expanding rapidly. Developments in protein/peptide chemistry and in radi ochemistry should lead to agents with very high specific activities. Recent ly, positron emission tomography with fluorine-18 fluorodeoxyglucose has be en shown to delineate infectious and inflammatory foci with high sensitivit y. The third millennium will witness a gradual shift from basic (non-specif ic) or cumbersome, even hazardous techniques (radiolabelled leucocytes) to more sophisticated approaches. Here a survey is presented of the different approaches in use or under investigation.